Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plectin is a giant, multidomain cytoskeletal protein (∼500 kDa) that acts as an essential crosslinker, connecting intermediate filaments, microtubules, and actin filaments across a wide variety of mammalian tissues[1][2][3][7][8]. It is the prototypical member of the plakin family and is structurally composed of N-terminal actin-binding domains, a central coiled-coil rod domain allowing dimerization, and a C-terminal filament-binding region[2][5][7]. Plectin binds and anchors cytoskeletal networks to junctional complexes (e.g., hemidesmosomes, desmosomes), organelles, and cell membrane sites, thus stabilizing cell architecture, maintaining tissue integrity, and allowing cells to withstand mechanical stress[1][2][3][7][8][10]. Its widespread expression and structural role underpin its involvement in diseases of mechanical fragility such as skin blistering disorders, muscular dystrophies, and certain cancers, typically due to gene mutations rather than as a therapeutic drug target[9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plectin (None).